Transcript levels of the intermediate size or grey zone fragile X mental retardation 1 alleles are raised, and correlate with the number of CGG repeats

Journal of Medical Genetics

Volumn 44, Issue 3, 2007, Pages 200-204

  Loesch, Danuta Z ^a   Bui, Quang M ^b   Huggins, Richard M ^b   Mitchell, Robert J ^a   Hagerman, Randi J ^c   Tassone, Flora ^d  

^a LA TROBE UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; MESSENGER RNA; FMR1 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ADOLESCENT; ADULT; ALLELE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; GENE MUTATION; GENE SILENCING; GENETIC TRANSCRIPTION; HETEROZYGOTE; HUMAN; LINEAR REGRESSION ANALYSIS; MALE; PHENOTYPE; PRIORITY JOURNAL; RNA TRANSLATION; TRANSCRIPTION INITIATION; TRINUCLEOTIDE REPEAT; BIOSYNTHESIS; FRAGILE X SYNDROME; GENETICS; STATISTICAL MODEL; UPREGULATION;

5' UNTRANSLATED REGIONS; ALLELES; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HUMANS; LINEAR MODELS; MALE; PHENOTYPE; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRINUCLEOTIDE REPEAT EXPANSION; UP-REGULATION;

EID: 34147169493     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.2006.043950     Document Type: Article

References (31)

1. Pieretti M, Zhang F, Fu YH, Warren ST, Oostra BA, Caskey CT, Nelson DL. Absence of expression of the FMR1 gene in the fragile X syndrome. Cell 1991;66:817-22.
2. Irwin SA, Galvez R, Greenough WT. Dendritic spine structural anomalies in fragile X mental retardation syndrome. Cereb Cortex 2000;10:1038-44.
3. Maddalena A, Richards CS, McGinnis MJ, Brothman A, Desnick RJ, Grier RE, Hirsch B, Jacky P, McDowell G, Popovich B, Watson M, Wolff DJ. Technical standards and guidelines tor fragile X: the first series of disease-specific supplements to the Standards and Guidelines for Clinical Genetic Laboratories of the White American College of Medical Genetics. Quality Assurance Subcommittee of the Laboratory Practice Committee. Genet Med 2001;3:200-5.
4. Fu YH, Kuhl DPA, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, Verkerk AJ, Holden JJ, Fenwick RG, Warren ST. Variation of the CGG repeat X site results in genetic instability. Resolution of Sherman paradox. Cell 1991;67:1047-58.
5. Tassone F, Hagerman RJ, Taylor AK, Mills JB, Wood S, Gone L, Hagerman PJ. Clinical involvement and protein expression in individuals with the FMR1 premutation. Am J Med Genet 2000;91:144-52.
6. Kenneson A, Zhang F, Hagedorn CH, Warren ST. Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum Mol Genet 2001;10:1449-54.
7. Primerano B, Tassone F, Hagerman RJ, Hagerman P, Amaldi F, Bagni C. Reduced FMR1 mRNA translation efficiency in Fragile X patients with premutations. RNA 2002;8:1482-8.
8. Tassone F, Hagerman RJ, Taylor AK, Gane LW, Godfrey TE, Hagerman PJ. Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile X syndrome. Am J Hum Genet 2000;66:6-15.
9. Loesch DZ, Huggins RM, Hagerman RJ. (2004) Phenotypic variation and FMRP levels in fragile X. Ment Retard Dev Disabil Res Rev 2004;10:31-41.
10. Allingham-Hawkins DJ, Babul-Hirji R, Chityat D, Holden JJA, Yang KT, Lee C, Hudson R, Gorwill H, Nolin SL, Glicksman A, Jenkins EC, Brown WT, Howard-Peebles PN, Beechi C, Cummings E, Fallon L, Seitz S, Black SH, Vianna-Morgante AM, Costa SS, Otto PA, Mingroni-Netto RC, Murray A, Webb J, Vieri F. Fragile X premutation is a significant risk factor for premature ovarian failure: the international collaborative POF in fragile X study-preliminary data. Am J Med Genet 1999;83:322-5.
11. Hagerman RJ, Leehey M, Heinrichs W, Tassone F, Wilson R, Hills J, Grigsby J, Gage B, Hagerman PJ. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 2001;57:127-30.
12. Loesch DZ, Churchyard A, Brotchie P, Marot M, Tassone F. Evidence for, and a spectrum of, neurological involvement in fragile X premutation: FXTAS and beyond. Clin Genet 2005;67:412-17.
13. Patsalis PC, Sismani C, Hettinger JA, Holden JJ, Lawson JS, Chalifoux M, Wing M, Walker M, Leggo J. Frequencies of 'grey zone' and premutation-size FMR1 CGG-repeat alleles in patients with developmental disability in Cyprus and Canada. Am J Med Genet 1999;84:195-7.
14. Bretherick KL, Fluker MR, Robinson WP. FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum Genet 2005;117:376-82.
15. Bodega B, Bione S, Dalpra L, Toniolo D, Ornaghi F, Vegetti W, Ginelli E, Marozzi A. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Hum Reprod 2006;21:952-7.
16. Mitchell RJ, Holden JJA, Zhang C, Curlis Y, Slater HR, Burgess T, Kirkby KC, Carmichael A, Heading KD, Loesch DZ. FMR1 (fragile X) alleles in Tasmania: a screening study of the special educational needs (SEN) population. Clin Genet 2005;67:38-46.
17. Allen EG, He W, Yadav-Shah M, Sherman SL. A study of the distributional characteristics of FMR1 transcript levels in 238 individuals. Hum Genet 2004;114:439-47.
18. Youings SA, Murray A, Dennis N, Ennis S, Lewis C, McKechnie N, Pound M, Macpherson JN, Dennis NR, Morton NE, Jacobs PA. FRAXA and FRAXE: the results of a five year study. J Med Genet 2000;37:415-21.
19. Chen L-S, Tassone F, Sahota P, Hagerman PJ. The (CGG)., repeat element within the 5′ untranslated region of the FMR1 message provides both positive and negative cis effects on in vivo translation of a downstream reporter. Hum Mol Genet 2003;12:3067-74.
20. Tassone F, Hagerman RJ, Garcia-Arocena D, Khandjian D, Greco CM, Hagerman PJ. Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ataxia syndrome. J Med Genet 2004;41:e43.
21. Saluto A, Brussino A, Tassone F, Arduino C, Cagnoli C, Pappi P, Hagerman P, Migone N, Brusco A. An enhanced polymerase chain reaction assay to detect pre-and full mutation alleles of the fragile X mental retardation 1 gene. J Mol Diagn 2005;5:605-12.
22. Loader C. Local Regression and Likelihood. New York: Springer-Verlag, 1999.
23. Muggeo VMR. Estimating regression models with unknown break-points. Slat Med 2003;22:3055-71.
24. R Development Core Team. R. A language and environment for statistical computing. Vienna, Austria: R Foundation for statistical computing, 2004, http://www.R-project.org (accessed 27 Oct 2006).
25. Tassone F, Beilina A, Carosi C, Albertosi S, Bagni C, Li L, Glover K, Bentley D, Hagerman PJ. Elevated FMR1 mRNA in premutation carriers is due to increased transcription. RNA 2007 (in press).
26. Tassone F, Iwahashi C, Hagerman PJ. FMR1 RNA within the intranuclear inclusions of fragile X-associated tremor/ataxia syndrome (FXTAS). RNA Biol 2004;1:103-5.
27. Jin P, Zarnescu DC, Zhang F, Pearson CE, Lucchesi JC, Moses K, Warren ST. RNA-mediated neurodegeration caused by the fragile X premutation rCGG repeats in Drosophila. Neuron 2003;39:739-47.
28. Mazzocco MM, Sonna NL, Teisl JT, Pinit A, Shapiro BK, Shah N, Reiss AL. The FMR1 and FMR2 mutations are not common etiologies of academic difficulty among school-age children. J Dev Behav Pediatr 1997;18:392-8.
29. Haddad LA, Aguiar MJB, Costa SS, Mingroni-Netto RC, Vianna-Morgante AM, Pena SD. Fully mutated and grey zone FRAXA alleles in Brazilian mentally retarded boys. Am J Med Genet 1999;84:198-01.
30. Crawford DC, Meadows KL, Newman JL, Taft LF, Pettay DL, Gold LB, Hersey SJ, Hinkle EF, Stanfield ML, Holmgreen P, Yeargin-Allsop M, Boyle C, Sherman SL. Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large ethnically, diverse, special education-needs population. Am J Hum Genet 1999;64:495-507.
31. Sullivan AK, Crawford DC, Scott EH, Leslie ML, Sherman SL. Paternally transmitted FMR1 alleles are less stable than maternally transmitted alleles in the common and intermediate size range. Am J Hum Genet 2002;70:1532-44.